Unified all-atom molecule generation with neural fields
By: Matthieu Kirchmeyer , Pedro O. Pinheiro , Emma Willett and more
Potential Business Impact:
Designs new medicines by looking at their shapes.
Generative models for structure-based drug design are often limited to a specific modality, restricting their broader applicability. To address this challenge, we introduce FuncBind, a framework based on computer vision to generate target-conditioned, all-atom molecules across atomic systems. FuncBind uses neural fields to represent molecules as continuous atomic densities and employs score-based generative models with modern architectures adapted from the computer vision literature. This modality-agnostic representation allows a single unified model to be trained on diverse atomic systems, from small to large molecules, and handle variable atom/residue counts, including non-canonical amino acids. FuncBind achieves competitive in silico performance in generating small molecules, macrocyclic peptides, and antibody complementarity-determining region loops, conditioned on target structures. FuncBind also generated in vitro novel antibody binders via de novo redesign of the complementarity-determining region H3 loop of two chosen co-crystal structures. As a final contribution, we introduce a new dataset and benchmark for structure-conditioned macrocyclic peptide generation. The code is available at https://github.com/prescient-design/funcbind.
Similar Papers
Fitness aligned structural modeling enables scalable virtual screening with AuroBind
Machine Learning (CS)
Finds new medicines for hard-to-treat diseases.
UniMoMo: Unified Generative Modeling of 3D Molecules for De Novo Binder Design
Machine Learning (CS)
Designs many kinds of medicine with one tool.
Concept-Driven Deep Learning for Enhanced Protein-Specific Molecular Generation
Machine Learning (CS)
Designs new medicines that fit the body.